ROC Venture Group — Full Portfolio
11 tracked investments · listed companies and verified rows first
MC Sciences is a biotech company developing first-in-class mast cell therapeutics based on a discovered mast cell receptor, aimed at diseases across immunology, dermatology, respiratory, gastrointestinal, fibrotic and chronic inflammatory conditions such as chronic urticaria, systemic mastocytosis, COPD, asthma and MCAS.
BiotechHealthtech
Gerhard J. Molderings(Founder)Wolfgang Taumann(CEO & Co-Founder)in
BoardMikael Dolsten(Board Chairman)
Co-investorsLifeArc Ventures
Data science platform for complex litigation (formerly ClaimScore)
Education company and 2025 Hi-Tech Awards finalist
Co-investorsArc AngelsIcehouse VenturesMovacVerlinvest
GrubMarket is a food tech company operating a B2B and B2C marketplace in the U.S. and Canada, offering both wholesale produce delivery at discounted prices and AI-powered SaaS software solutions for food supply chain businesses including inventory management, warehouse operations, and eCommerce platforms.
B2B MarketplacesE-commerceEnterprise SoftwareFoodTechLogistics & Supply ChainSaaSSan Francisco, US
Mike Xu(Founder/CEO, , President)in
Co-investorsBascom VenturesBattery VenturesBuilders + BackersCastor Ventures (an Alumni Ventures Fund)Celtic House Asia PartnersDisruptive Ventures+23 more
MoxiWorks provides a real estate marketing and CRM platform for brokerages and agent teams, covering lead management, CMA and presentation building, advertising, email marketing, and agent websites.
AI & Machine LearningEnterprise SoftwareMarketing TechPropTechSaaSSeattle, US
Co-investorsVector Capital
Robotics company that exited stealth with a $450M Series A to bring robots into real-world use
Cybersecurity and data observability service
New York, US
Tony Tontat(Executive Officer)Jason Turner(Executive Officer, Director)
Technology company developing an oscillator-based architecture for efficient inference
Consumer product company that surpassed 2.5 million units sold in its first year
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
